The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 137

Sleep Data Tincture Research and Development 137

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 252

Chronic Pain Therapy Patients Topical 252

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 127

Data Research and Development Patients Strains 127

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 215

Chronic Pain Patients Therapy Data 215

Canna Care Docs

JUNE 5, 2025

The Changing Landscape of Me dical Marijuana in Massachusetts: What Patients Should Know The Massachusetts medical marijuana program has been a cornerstone of cannabis access since its inception in 2012. Approximately 94 medical dispensaries remain statewide, compared to over 350 recreational.

Patients 52

Patients Advocacy Marijuana Programs 52

NORML

AUGUST 26, 2019

While patients won’t be rolling up joints full of pungent flower, they can still access oils, tinctures, lozenges, inhalers, topicals, and pills packed with non-intoxicating CBD or THC-A, the acidic precursor of THC. The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. We need to do more.

Marijuana 226

Marijuana Legalization Programs Oil 226

Canna Law Blog

MARCH 25, 2025

The conditions of the relevant licenses and permits. Several proposals aim to: Expand medicinal cannabis access. Data Privacy 29. What data privacy obligations do cannabis businesses have? Valid consent for data collection and use. Chain of custody requirements for comprehensive tracking. simplified licensing).

Research and Development 95

Research and Development Medicine Compliance Compliance 95

Cannabis Law Report

AUGUST 23, 2021

They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic.

Patients 111

Patients Chronic Pain Marijuana Conditions 111

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

LifeCannMD

APRIL 28, 2025

For an engineer like Rick, who understood the value of evidence and data, it was a revelation. Instead, he wanted everyone to have access to it. Cancer patients, folks with chronic pain, people suffering from conditions their doctors couldn’t fixthey all found their way to Rick’s door. Never charged a dime.

History 82

History Chronic Pain Research and Development Oil 82

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 111

Consumption Patients Research and Development Data 111

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Under what conditions can the deal be terminated? Access Psychiatry deal headline, upfront, milestone and royalty data.

Access 40

Access Data Pharmaceutical Research and Development 40

Cannabis Law Report

JUNE 5, 2021

” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. Why does Argentina have the conditions to be an important producer in the cannabis and hemp industry? ley cáñamo argentina. ley cáñamo argentina. Employment: Generation of quality jobs.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Veriheal

SEPTEMBER 13, 2022

Grow rooms require ventilation, lights, environmental controls, and other optimal environmental conditions in order for cannabis plants to thrive. Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 111

Cultivation Data DEA Dispensary 111

Cannabis Law Report

JULY 5, 2021

The ERP operates as a system, collecting data in real time and connecting it all together for your. Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled. and each user can only access part of the information. Some users can have unique privileges to.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease.

Patients 107

Patients Clinical Trials Research and Development Treatment 107

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 81

CBD Data Sleep Clinical Trials 81

Veriheal

AUGUST 15, 2022

The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. The sessions were logged by a total of 1,224 people who had access to the app. The Releaf App’s Role in the Fatigue Study.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.” All imaging and behavioral data will be accessible to the public after the study is complete.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

MMJ Recs

AUGUST 30, 2021

Since these beginnings in 2014, many other changes surrounding the use and possession of medical marijuana have been put into place in Missouri so the state can provide legal medical marijuana to patients suffering from a variety of approved conditions. Is medical marijuana being sold in Missouri yet?

Seed-To-Sale 98

Seed-To-Sale Business Marijuana Dispensary 98

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Additional information on these resources and how to access them can be found here.

Conditions 52

Conditions Dispensary Programs Business 52

Cannabis Law Report

AUGUST 27, 2021

The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. New applicants may apply for either a conditional license or an annual license.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Veriheal

DECEMBER 9, 2021

Those who support cannabis have used the evidence of its ability to treat mental conditions like post-traumatic stress disorder (PTSD) to rebuke claims of a link between cannabis and mental illness. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

Veriheal

AUGUST 17, 2022

Data that’s been published on the subject have been contradictory. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). Pros and cons of any cannabis-related topic should be made easily accessible in relation to a study’s findings.

Research and Development 105

Research and Development Topical Data Cannabis 105

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon.

Access 52

Access Patients Research and Development Treatment 52

SpeedWeed

JULY 10, 2021

The law also expands the qualifying conditions for eligibility to include cancer remission therapy, as well as spinal cord or central nervous system damage with “indication of intractable spasticity and other associated neuropathies,” according to the bill’s text. In addition, H.B. That list will be updated annually. View original article.

Access 52

Access Research and Development Programs Legislation 52

The Cannigma

MARCH 25, 2021

When the law changed in the UK in 2018, I was humbled by the efforts of those who suffer on a daily basis to achieve legal access to medicinal cannabis. These qualities are necessary to ensure that the private medical cannabis space conducts itself with compassion and respect for those who are accessing medication through it.

Patients 145

Patients Clinical Trials Medicine Events 145

Veriheal

DECEMBER 14, 2023

The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronic pain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 122

Chronic Pain Consumption Cannabis Marijuana 122

Cannabis Law Report

JULY 6, 2021

High Tide gains access to Daily High Club’s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. 1 As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. Traffic data provided by Google Analytics.

Consumption 116

Consumption Retail Media Events 116